James Armitage Net Worth & Insider Trades

James Armitage - Director, Cardiff Oncology, Inc

As of October 11, 2022

What is James Armitage's Net Worth?

The current estimated net worth of Cardiff Oncology, Inc's Director, James Armitage, is estimated to be about $1.3M . James Armitage owns about 13,000 units of Cardiff Oncology, Inc common stock. In the last 2 years at Cardiff Oncology, Inc, James Armitage has sold an estimated value of $0 worth.

What is James Armitage's Past Insider Trading?

James Armitage's largest purchase order was 4,000 units , worth over $43.27K on May 27, 2021. In total, James Armitage has made about 6 transactions over 2 years of their time at Cardiff Oncology, Inc. James Armitage usually trades in May and June, with the busiest year in 2020, 2022 and 2021. The most recent transaction was a purchase order of 13,000 units , worth over $20.23K on October 11, 2022.

James Armitage

Date Range: All Time
Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1

What is James Armitage's' Mailing Address?

  • Mailing address is C/o Tesaro, Inc. 1000 Winter St., Suite 3300 Waltham MA 02451 MA

What are Cardiff Oncology, Inc's Past Insider Trades?

Cardiff Oncology, Inc's most recent insider trade came on November 29, 2022 by Mark Erlander who bought 10,000 units worth $14.3K . In the last 2 years, insiders at Cardiff Oncology, Inc have sold an estimated value of $657.02K and bought an estimated value of $2.06M worth of shares. Insider trading is most common in June, with the busiest year in 2021. The most active traders at the company are Gary Pace, Director,  Mark Erlander, Chief Executive Officer,  and James Armitage, Director .

Cardiff Oncology, Inc. Insider Trades

Date Range: All Time
Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1